DIETHYLPROPION HYDROCHLORIDE (TENUATE-DOSPAN) IN COMBINATION WITH HYPOTENSIVE AGENTS IN TREATMENT OF OBESITY ASSOCIATED WITH HYPERTENSION

被引：0
|
作者：
SEEDAT, YK
REDDY, J
机构：
[1] UNIV NATAL,DEPT MED,HYPERTENSION CLIN,RENAL UNIT,DURBAN,SOUTH AFRICA
[2] KING EDWARD VIII HOSP,DURBAN,SOUTH AFRICA
来源：
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1974年 / 16卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：398 / 413
页数：16
相关论文
共 50 条
  • [31] Transgenic approach toward leptin biology: The clinical implications of leptin for the treatment of obesity-associated diabetes and obesity-related hypertension
    Masuzaki, H
    Ogawa, Y
    Aizawa-Abe, M
    Nakao, K
    ENDOCRINE JOURNAL, 2002, 49 (02) : 109 - 119
  • [32] A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension
    J B Byrd
    R D Brook
    Journal of Human Hypertension, 2014, 28 : 3 - 9
  • [33] COMBINATION OF BETA-RECEPTOR BLOCKING-AGENTS AND - SALURETICA IN OUTPATIENT TREATMENT OF HYPERTENSION - RESULTS OF A COMPARATIVE-STUDY
    HOFFMANN, J
    SCHREY, A
    GRUND, R
    FORST, T
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1981, 123 (12): : 483 - 488
  • [34] Paternal cholestasis exacerbates obesity-associated hypertension in male offspring but is prevented by paternal ursodeoxycholic acid treatment
    Vanessa Pataia
    Georgia Papacleovoulou
    Vanya Nikolova
    Anne-Maj Samuelsson
    Stephanie Chambers
    Eugene Jansen
    Paul D Taylor
    Lucilla Poston
    Catherine Williamson
    International Journal of Obesity, 2019, 43 : 319 - 330
  • [35] Sodium-Glucose Cotransporter Protein 2 Inhibitors: Novel Application for the Treatment of Obesity-Associated Hypertension
    Hu, Yilan
    Bao, Jiaqi
    Gao, Zhicheng
    Ye, Lifang
    Wang, Lihong
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 407 - 415
  • [36] Paternal cholestasis exacerbates obesity-associated hypertension in male offspring but is prevented by paternal ursodeoxycholic acid treatment
    Pataia, Vanessa
    Papacleovoulou, Georgia
    Nikolova, Vanya
    Samuelsson, Anne-Maj
    Chambers, Stephanie
    Jansen, Eugene
    Taylor, Paul D.
    Poston, Lucilla
    Williamson, Catherine
    INTERNATIONAL JOURNAL OF OBESITY, 2019, 43 (02) : 319 - 330
  • [37] Effects of treatment with a combination of cardiac rehabilitation and bosentan in patients with pulmonary Langerhans cell histiocytosis associated with pulmonary hypertension
    Fukuda, Yusuke
    Miura, Shin-ichiro
    Fujimi, Kanta
    Yano, Masaya
    Nishikawa, Hiroaki
    Yanagisawa, Jun
    Hiratsuka, Masafumi
    Shiraishi, Takeshi
    Iwasaki, Akinori
    Saku, Keijiro
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (12) : 1481 - 1483
  • [38] Upfront combination therapy in the treatment of scleroderma-associated pulmonary arterial hypertension: Results of an open label trial
    Hassoun, Paul
    Zamanian, Roham
    Damico, Rachel
    Khair, Rubina
    Kolb, Todd
    Tedford, Ryan
    Hulm, Olivia
    Pisanello, Chiara
    Sato, Takahiro
    Corona-Villalobos, Cecilia
    Zimmerman, Stefan
    Gashouta, Mohamed
    Minai, Omar
    Torres, Fernando
    Chin, Kelly
    Girgis, Reda
    Mathai, Stephen
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [39] Comparative analysis of arterial hypertension treatment in men and women based on the results of ACCORD study (ACridilole in Combination therapy in patients with arterial hypertension and Obesity oR type 2 Diabetes)
    Shalnova, S. A.
    Martsevich, S. Yu.
    Deev, A. D.
    Lukina, Yu. V.
    Hoseva, E. N.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2011, 7 (03) : 288 - 293
  • [40] Akridilol (Carvedilol) in combination treatment in patients with essential hypertension and obesity and/or type 2 diabetes mellitus: A randomized trail (ACCORD-study)
    Shalnova, S.
    Deev, A.
    Martsevich, S.
    JOURNAL OF HYPERTENSION, 2008, 26 : S224 - S224
12345